ITUA20162486A1 - Nanobolle e relativi impieghi - Google Patents

Nanobolle e relativi impieghi

Info

Publication number
ITUA20162486A1
ITUA20162486A1 ITUA2016A002486A ITUA20162486A ITUA20162486A1 IT UA20162486 A1 ITUA20162486 A1 IT UA20162486A1 IT UA2016A002486 A ITUA2016A002486 A IT UA2016A002486A IT UA20162486 A ITUA20162486 A IT UA20162486A IT UA20162486 A1 ITUA20162486 A1 IT UA20162486A1
Authority
IT
Italy
Prior art keywords
nanobubbles
Prior art date
Application number
ITUA2016A002486A
Other languages
English (en)
Inventor
Maria Carafa
Andrea Bettucci
Carlotta Marianecci
Federica Rinaldi
Angelo Biagioni
Original Assignee
Univ Degli Studi Roma La Sapienza
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Degli Studi Roma La Sapienza filed Critical Univ Degli Studi Roma La Sapienza
Priority to ITUA2016A002486A priority Critical patent/ITUA20162486A1/it
Priority to PCT/IB2017/052060 priority patent/WO2017178954A1/en
Publication of ITUA20162486A1 publication Critical patent/ITUA20162486A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6925—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a microcapsule, nanocapsule, microbubble or nanobubble

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acoustics & Sound (AREA)
  • Nanotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
ITUA2016A002486A 2016-04-11 2016-04-11 Nanobolle e relativi impieghi ITUA20162486A1 (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ITUA2016A002486A ITUA20162486A1 (it) 2016-04-11 2016-04-11 Nanobolle e relativi impieghi
PCT/IB2017/052060 WO2017178954A1 (en) 2016-04-11 2017-04-10 Nanobubbles and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITUA2016A002486A ITUA20162486A1 (it) 2016-04-11 2016-04-11 Nanobolle e relativi impieghi

Publications (1)

Publication Number Publication Date
ITUA20162486A1 true ITUA20162486A1 (it) 2017-10-11

Family

ID=56555546

Family Applications (1)

Application Number Title Priority Date Filing Date
ITUA2016A002486A ITUA20162486A1 (it) 2016-04-11 2016-04-11 Nanobolle e relativi impieghi

Country Status (2)

Country Link
IT (1) ITUA20162486A1 (it)
WO (1) WO2017178954A1 (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2019131723A1 (ja) * 2017-12-27 2021-01-14 武田薬品工業株式会社 薬物の投与方法
US20230293720A1 (en) * 2022-01-21 2023-09-21 Sohini Banerjee Novel nanobubble that contains epilepsy medicine. The bubble polarizes in presence of the electric surge generated in the brain during an epilepsy attack and automatically discharges the medicine at the time and the site of the attack, stopping the seizure in its infancy without any external intervention. The bubble releases just enough medication into the bloodstream, significantly reducing side effects.
CN116370658A (zh) * 2023-03-08 2023-07-04 中国科学院深圳先进技术研究院 一种靶向肿瘤的超声造影剂及其制备方法和应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014054026A1 (en) * 2012-10-04 2014-04-10 University Of The Witwatersrand, Johannesburg Liposomal drug delivery system
US20140147390A1 (en) * 2010-09-24 2014-05-29 Agata Exner Stabilized nanobubbles for diagnostic and therapeutic applications

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140147390A1 (en) * 2010-09-24 2014-05-29 Agata Exner Stabilized nanobubbles for diagnostic and therapeutic applications
WO2014054026A1 (en) * 2012-10-04 2014-04-10 University Of The Witwatersrand, Johannesburg Liposomal drug delivery system

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
HUANG S L ET AL: "A Method to Co-Encapsulate Gas and Drugs in Liposomes for Ultrasound-Controlled Drug Delivery", ULTRASOUND IN MEDICINE AND BIOLOGY, NEW YORK, NY, US, vol. 34, no. 8, 1 August 2008 (2008-08-01), pages 1272 - 1280, XP023176831, ISSN: 0301-5629, [retrieved on 20080414], DOI: 10.1016/J.ULTRASMEDBIO.2008.01.005 *
KOHSUKE HAGISAWA ET AL: "Enhancement of ultrasonic thrombus imaging using novel liposomal bubbles targeting activated platelet glycoprotein IIb/IIIa complex andstudy", INTERNATIONAL JOURNAL OF CARDIOLOGY, ELSEVIER, AMSTERDAM, NL, vol. 152, no. 2, 4 July 2010 (2010-07-04), pages 202 - 206, XP028305508, ISSN: 0167-5273, [retrieved on 20100717], DOI: 10.1016/J.IJCARD.2010.07.016 *
NICOLAS SAX ET AL: "Optimization of Acoustic Liposomes for Improved In vitro and In vivo Stability", PHARMACEUTICAL RESEARCH, KLUWER ACADEMIC PUBLISHERS-PLENUM PUBLISHERS, NL, vol. 30, no. 1, 1 September 2012 (2012-09-01), pages 218 - 224, XP035152043, ISSN: 1573-904X, DOI: 10.1007/S11095-012-0864-8 *
TSONG-LONG HWANG ET AL: "Development and evaluation of perfluorocarbon nanobubbles for apomorphine delivery", JOURNAL OF PHARMACEUTICAL SCIENCES, vol. 98, no. 10, 1 October 2009 (2009-10-01), pages 3735 - 3747, XP055195470, ISSN: 0022-3549, DOI: 10.1002/jps.21687 *

Also Published As

Publication number Publication date
WO2017178954A1 (en) 2017-10-19

Similar Documents

Publication Publication Date Title
DK3405050T3 (da) Børnesikret snusbeholder
MA40933A (fr) Difluorométhyl-aminopyridines et difluorométhyl-aminopyrimidines
DK3436823T3 (da) Antigen-array
DK3335532T3 (da) Tandharve
DK3445708T3 (da) Stigbøjle
DK3402792T3 (da) Quinolin-2-on-derivater
DK3161139T3 (da) Tlr-4-specifikke aptamerer og anvendelser heraf
DK3509963T3 (da) Pallecontainer
DK3528829T3 (da) Bacitracin-alginat-oligomer-konjugater
DK3408265T3 (da) Terapeutiske forbindelser
DK3575238T3 (da) Pallecontainer
DE112017006386A5 (de) Schraubarbeitszylinder
DE112017000734A5 (de) Glycolsensor
DK3323708T3 (da) Bovfender
ITUA20162486A1 (it) Nanobolle e relativi impieghi
DK3471535T3 (da) Dyrelift
DK3452587T3 (da) Penicillin-g-acylaser
DK3452590T3 (da) Plademagnet
DK3430609T3 (da) Smartflag
DK3295800T3 (da) Sandwichkiksindretning
DE112017006474A5 (de) Gargerätevorrichtung
DK3551954T3 (da) Rekuperator
DE112017005767A5 (de) Nasslaufende lamellenkupplung
DK3468607T3 (da) Resveratrolsolubilisat
DE112017000296A5 (de) Radgeschwindigkeitssensorvorrichtung